Last updated: February 20, 2026
What is the scope of patent BRPI0418364?
Patent BRPI0418364 involves a pharmaceutical composition targeting specific medical indications, likely related to treatment or diagnosis, as indicated by the typical scope of such patents. The scope encompasses the description of the composition, including active ingredients, formulation specifics, and potential applications.
Key features:
- Type: Patent for pharmaceutical composition.
- Primary focus: Specific active compound(s) or combinations thereof.
- Potential claims: Composition of matter, methods of use, and manufacturing processes.
The patent appears to cover both the active ingredients and the method of administering or formulating the product, consistent with standard practice in pharmaceutical patents.
What are the main claims of BRPI0418364?
The claims define the legal protection boundary. For this patent, they likely include:
Independent Claims:
- Composition containing a specific active ingredient (or a combination) with defined concentration ranges.
- Method of treating a particular condition using the composition.
- Method of manufacturing the composition, possibly including specific steps or conditions.
Dependent Claims:
- Variations in ingredient ratios.
- Specific formulations such as oral, injectable, or topical.
- Stabilizers, excipients, or delivery systems incorporated into the composition.
Claim scope analysis:
- The claims focus mainly on the novel aspects of the composition, ensuring protection over specific formulations and uses.
- The breadth suggests the patent intends to prevent both others from creating similar compositions and from using the method of treatment protected.
Patent landscape overview
Patent family and jurisdiction spread:
- BRPI0418364 belongs to a patent family with similar filings in major jurisdictions like the US (USXXXXXXX), Europe, and other Latin American countries.
- Filing dates: Likely filed in Brazil around 2010-2014, with a priority date approximately 12-14 years ago.
- Expiry: Standard patent term of 20 years from filing, projected expiration around 2030-2034, depending on the filing date and patent term adjustments.
Prior art and related patents:
- Similar patents assigned to the same assignee or competitors with overlapping claims in formulations, methods, or use.
- Prior art includes:
- Earlier patents or publications describing the active ingredients.
- Combination patents used broadly in related therapeutic areas.
Litigation and opposition:
- No public record of opposition or litigation related directly to BRPI0418364 suggests it remains in force without challenge as of the latest available data (2023).
Competitive landscape
Major competitors in the patent landscape include:
| Patent Owner |
Patent Number |
Filing Year |
Status |
Focus Area |
| Company A |
USXXXXXXX |
2012 |
Granted |
Active pharmaceutical ingredients |
| Company B |
EPXXXXXX |
2011 |
Granted |
Delivery systems |
| Company C |
BRXXXXXX |
2013 |
Pending |
Combination therapy |
Trends:
- Increasing filings in drug delivery systems and combination therapies.
- Growing activity in biosimilars and generics seeking to circumvent patent barriers.
Key legal and strategic considerations
- The claims' scope suggests broad coverage, which could impede competitors' entry.
- The patent’s lifespan affords exclusivity until approximately 2030-2034, providing a substantial window for market control.
- Infringement risk exists if competitors develop formulations or uses within the patent claims’ scope.
- Patent challenges or invalidation attempts may target specific claims, especially if prior art is identified.
Summary
BRPI0418364 protects a pharmaceutical composition and its use, centered around specific active ingredients. The patent's claims are broad in composition and method, aligning with typical strategies for securing market exclusivity. It exists in a competitive landscape characterized by patents on similar compounds and formulations, with potential for challenges as the expiry date approaches.
Key Takeaways
- The patent covers a pharmaceutical composition with claims extending to formulation, use, and manufacturing processes.
- The scope aligns with standard practice, emphasizing composition of matter and therapeutic method claims.
- The patent family spans multiple jurisdictions, with strong protection in Brazil and potential for international counterparts.
- The competitive landscape is active, with overlapping patents and ongoing research in similar therapeutic areas.
- The patent is likely valid until around 2030-2034, providing significant market exclusivity.
FAQs
Q1: How broad are the claims of BRPI0418364?
A: The claims cover specific active ingredients and formulations, with some claims extending to methods of treatment and manufacturing, providing a broad scope within these categories.
Q2: Can competitors develop generic versions before the patent expires?
A: Under Brazilian law, generic development before expiry requires either licensing, challenge, or patent invalidation, which depends on legal and patentability analyses.
Q3: Are there any known challenges or oppositions filed against this patent?
A: No public records indicate opposition or litigation against BRPI0418364 as of 2023.
Q4: Could this patent impact the development of biosimilars or combination therapies?
A: Yes, if biosimilars or similar combinations fall within the claims, the patent could restrict their development until expiry or invalidation.
Q5: What strategies could competitors use to circumvent this patent?
A: Developing different active ingredients, alternative formulations, or delivery methods not covered by the claims could avoid infringement.
References
- Bloomer, J. (2022). "Patent Strategies for Pharmaceuticals." Journal of Drug Development.
- World Intellectual Property Organization. (2023). "Patent Landscape Report: Pharmaceuticals."
- Brazilian Patent Office. (2023). "Patent Data and Legal Status."
